Embleema’s blockchain network offers a novel way to put patients at the center of clinical research.
Embleema has raised €3.2M across 1 funding round from 2 investors, most recently a Series A round in Jan 2019. Based in Paris, France; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €3.2M |
| Pharmagest,Techstars |
| View deal → |
